JPWO2020172686A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020172686A5 JPWO2020172686A5 JP2021549163A JP2021549163A JPWO2020172686A5 JP WO2020172686 A5 JPWO2020172686 A5 JP WO2020172686A5 JP 2021549163 A JP2021549163 A JP 2021549163A JP 2021549163 A JP2021549163 A JP 2021549163A JP WO2020172686 A5 JPWO2020172686 A5 JP WO2020172686A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- nos
- iapp peptide
- iapp
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- PLOPBXQQPZYQFA-AXPWDRQUSA-N Amlintide Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)CSSC1)[C@@H](C)O)C(C)C)C1=CC=CC=C1 PLOPBXQQPZYQFA-AXPWDRQUSA-N 0.000 claims 18
- 102000036849 Islet amyloid polypeptide Human genes 0.000 claims 18
- 108010041872 Islet amyloid polypeptide Proteins 0.000 claims 18
- 125000003275 alpha amino acid group Chemical group 0.000 claims 5
- 206010002022 Amyloidosis Diseases 0.000 claims 3
- 206010012601 Diabetes mellitus Diseases 0.000 claims 1
- 230000002776 aggregation Effects 0.000 claims 1
- 238000004220 aggregation Methods 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 239000000546 pharmaceutic aid Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962809167P | 2019-02-22 | 2019-02-22 | |
US62/809,167 | 2019-02-22 | ||
PCT/US2020/019557 WO2020172686A1 (en) | 2019-02-22 | 2020-02-24 | Amyloid peptide variants |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2022521266A JP2022521266A (ja) | 2022-04-06 |
JPWO2020172686A5 true JPWO2020172686A5 (zh) | 2022-11-14 |
JP7505713B2 JP7505713B2 (ja) | 2024-06-25 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5042312B2 (ja) | Hghを含む経口送達用医薬組成物 | |
RU2466738C2 (ru) | Фрагменты vip и способы их применения | |
JP2022191257A5 (zh) | ||
JP2008501723A (ja) | 循環器病の治療のための組成物および方法 | |
JP2009544585A5 (zh) | ||
EP3846821B1 (en) | Combination therapy for the treatment of liver disease | |
JP2021502392A5 (zh) | ||
US10076511B2 (en) | Bisamide derivative of dicarboxylic acid as an agent for stimulating tissue regeneration and recovery of diminished tissue function | |
JP2002511875A (ja) | 勃起機能障害治療用のヨヒンビンおよびアルギニン含有薬 | |
WO2022042541A1 (zh) | 眼镜蛇蛇毒或其提取物在制备降尿酸和/或抗痛风性关节炎的药物中的应用 | |
JP2002530353A5 (zh) | ||
US11628163B2 (en) | 1-piperidinepropionic acid for treating a fibrosing disease | |
JPWO2020172686A5 (zh) | ||
US3681497A (en) | Therapeutic methods of employing hydrogen maleate salt of n-(d-6-methyl-8-isoergolenyl)-n{40 ,n{40 -diethyl-carbamide | |
WO2019171333A1 (en) | Treatment of demyelinating diseases | |
TAUBENHAUS et al. | Clinical and histological observations on a case of scleroderma treated with cortisone | |
JP2022035920A5 (zh) | ||
JP2004529158A5 (zh) | ||
JP5667238B2 (ja) | 治療のためのヒストンの使用方法 | |
JP2001089370A (ja) | 肝疾患治療剤 | |
Naqoosh et al. | A rare case of Mandibular Mucormycosis in a Post-COVID-19 patient | |
WO2021024855A1 (ja) | 線維筋痛症の治療薬又は予防薬 | |
WO1999039703A1 (fr) | Medicaments preventifs et curatifs de troubles de la muqueuse intestinale | |
JPWO2021021915A5 (zh) | ||
JPWO2019152627A5 (zh) |